PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

P3 Health Partners Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from P3 Health Partners Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Assets Ratio: Of every $100 the company owns, $25 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 96% of Healthcare companies in United States.
  • Cash Cushion Ratio: Debt, after subtracting cash, equals 29% of its market value (net debt). Lower than 88% of Healthcare companies in United States.

Where $100 of sales goes

$119Operating costs$3.8Interest$10Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

2/3 · 1/3

Sales grew in 2 of the last 3 years; profit grew in 1 of 3.

Steadier than 50% of Healthcare companies in United States.

Growth Efficiency Ratio

$30

Sales grew 39% in 3 years; of every extra $100 of sales, $30 became extra profit.

Higher than 57% of Healthcare companies in United States.

Asset Productivity Ratio

+39% / -25%

In 3 years sales changed by +39% while total assets changed by -25%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

-2.0×

Operating cash was negative last year, while some debt falls due within a year.

Higher than 64% of Healthcare companies in United States.

Cash Cushion Ratio

−29%

Debt, after subtracting cash, equals 29% of its market value (net debt).

Lower than 88% of Healthcare companies in United States.

Tangible Assets Ratio

25%

Of every $100 the company owns, $25 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 96% of Healthcare companies in United States.

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+295%

Share count rose 295% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 81% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

P3 Health Partners Inc. made a loss over the last year. P3 Health Partners Inc. owes $0.79 for every $1 it owns. P3 Health Partners Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

P3 Health Partners Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

12.31

The share price is 12.31 times P3 Health Partners Inc.'s book value per share, higher than 88% of Healthcare companies in United States.

Market cap

$889 M

The total market value of all of P3 Health Partners Inc.'s shares at today's price (share price × number of shares), larger than 62% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

$72 M

What P3 Health Partners Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.35

Net worth divided by the number of shares. The share price of $4.36 is 12.3 times this, which is the P/B above.

Return on equity (ROE)

-192.6%

P3 Health Partners Inc. lost 192.6% of its shareholders' money over the last year, lower than 84% of Healthcare companies in United States.

Owes vs Owns

0.79×

P3 Health Partners Inc. owes $0.79 for every $1 it owns (moderate), higher than 77% of Healthcare companies in United States.

Dividend yield

None

P3 Health Partners Inc. does not currently pay a dividend.

Revenue growth

-3%

Revenue fell 3% in the year to Dec 2025, and grew 12% a year on average over 3 years.

Profit growth

Loss

P3 Health Partners Inc. made a loss in each of the last two years.

Profit margin

-10.1%

P3 Health Partners Inc. lost $10 for every $100 of revenue.

Interest cover

Not covered

P3 Health Partners Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

P3 Health Partners Inc. had $260 M more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For P3 Health Partners Inc.: $889 M ÷ $72 M (30 Jun 2026) = 12.3.

What is P3 Health Partners Inc.'s return on equity?

P3 Health Partners Inc. lost 192.6% of its shareholders' money over the last year, lower than 84% of Healthcare companies in United States.

How much does P3 Health Partners Inc. owe compared with what it owns?

P3 Health Partners Inc. owes $0.79 for every $1 it owns (moderate), higher than 77% of Healthcare companies in United States.

Does P3 Health Partners Inc. pay a dividend?

No. P3 Health Partners Inc. does not currently pay a dividend.

Is P3 Health Partners Inc.'s revenue growing?

Revenue fell 3% in the year to Dec 2025, and grew 12% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.